HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bradley S. Allen Michel N. Ilbawi Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kronon, M. T. Articles by Ilbawi, M. N. Search for Related Content PubMed PubMed Citation Articles by Kronon, M. T. Articles by Ilbawi, M. N.

Ann Thorac Surg 2000;70:765-770
© 2000 The Society of Thoracic Surgeons

---

Original articles: cardiovascular

Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate

^a Division of Pediatric Cardiovascular Surgery, The Heart Institute for Children, Hope Children’s Hospital, Oak Lawn, USA
^b The University of Illinois at Chicago, Chicago, Illinois, USA

Address reprint requests to Dr Allen, Heart Institute for Children, Hope Children’s Hospital, 4440 W 95th St, Oak Lawn, IL 60453

Presented at the Poster Session of the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Ft. Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. In adult cardiac operations, a warm cardioplegic reperfusate ("hot shot") before removing the aortic cross-clamp improves postbypass myocardial function and metabolic recovery. This modality, however, is rarely used in infants, despite the fact that postbypass cardiac dysfunction remains problematic, especially in cyanotic ("stressed") patients.

Methods. To produce stress, 15 neonatal piglets underwent 60 minutes of ventilator hypoxia (fraction of inspired oxygen, 8% to 10%). All piglets then received similar protection with multidose cold blood cardioplegic solution during 70 minutes of arrest and were separated into three groups to examine the role of a warm reperfusate as well as possible augmentation by aspartate and glutamate enrichment. In 5 piglets (group 1), the cross-clamp was simply removed; in 5 (group 2), an unsupplemented warm blood cardioplegic reperfusate was given; and in 5 (group 3), the warm reperfusate was enriched with aspartate and glutamate. Myocardial function was assessed using pressure-volume loops and expressed as a percentage of control.

Results. Compared with hearts receiving reperfusion with unmodified blood (group 1), a warm unsupplemented cardioplegic reperfusate (group 2) slightly improved systolic contractility (end-systolic elastance, 41% versus 50%; p < 0.05 versus group 1) and preload recruitable stroke work (41% versus 52%; p < 0.05 versus group 1), reduced diastolic stiffness (263% versus 245%; p < 0.05 versus group 1), and increased adenosine triphosphate (10.7 versus 11.9 µg/g tissue, p < 0.05 versus group 1). However, if aspartate and glutamate was included in the warm reperfusate (group 3), there was complete recovery of systolic function (end-systolic elastance, 105% ± 3%; p < 0.001 versus all groups) and preload recruitable stroke work (103% ± 2%; p < 0.001 versus all groups), a minimal rise in diastolic stiffness (154% ± 7%; p < 0.001 versus all groups), and preservation of adenosine triphosphate (15.5 ± 0.5 µg/g; p < 0.001 versus all groups).

Conclusions. A warm cardioplegic reperfusate helps reduce the reperfusion injury, resulting in improved myocardial function and metabolic recovery in hypoxic (stressed) neonatal hearts, and this effect is maximized if the reperfusate is enriched with aspartate and glutamate, which completely preserves myocardial function.

This article has been cited by other articles:

				C. Rergkliang, A. Chetpaophan, V. Chittithavorn, P. Vasinanukorn, and V. Chowchuvech Terminal Warm Blood Cardioplegia in Mitral Valve Replacement: Prospective Study Asian Cardiovasc Thorac Ann, April 1, 2006; 14(2): 134 - 138. [Abstract] [Full Text] [PDF]

				C. Schlensak Myocardial protection in congenital heart surgery MMCTS, November 29, 2005; 2005(1129): 729. [Abstract] [Full Text] [PDF]

				B. S. Allen Pediatric myocardial protection: Where do we stand? J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 11 - 13. [Full Text] [PDF]

				P. Modi, M.-S. Suleiman, B. Reeves, A. Pawade, A.J. Parry, G.D. Angelini, and M. Caputo Myocardial metabolic changes during pediatric cardiac surgery: A randomized study of 3 cardioplegic techniques J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 67 - 75. [Abstract] [Full Text] [PDF]

				B. S. Allen, M. Castella, G. D. Buckberg, and Z. Tan Conditioned blood reperfusion markedly enhances neurologic recovery after prolonged cerebral ischemia J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1851 - 1858. [Abstract] [Full Text] [PDF]

				Y. Toyoda, M. Yamaguchi, N. Yoshimura, S. Oka, and Y. Okita Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1242 - 1251. [Abstract] [Full Text] [PDF]

				B. S. Allen, J. S. Veluz, G. D. Buckberg, E. Aeberhard, and L. J. Ignarro Deep hypothermic circulatory arrest and global reperfusion injury: Avoidance by making a pump prime reperfusate--A new concept J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 625 - 632. [Abstract] [Full Text] [PDF]

				B. S Allen The role of leukodepletion in limiting ischemia/reperfusion damage in the heart, lung and lower extremity Perfusion, March 1, 2002; 17(2_suppl): 11 - 22. [Abstract] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, M. J. Barth, and M. Ilbawi Delivery of a nonpotassium modified maintenance solution to enhance myocardial protection in stressed neonatal hearts: A new approach J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 119 - 129. [Abstract] [Full Text] [PDF]